Page 318 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

292 Dimitri Chanouzas and Matthew David Morgan

[21] Reddi A, Chetty R. Primary aorto-oesophageal fistula due to Takayasu’s aortitis.
Cardiovasc. Pathol. 2003; 12:112-114.

[22] Hoffman GS, Leavitt RY, Kerr GS, et al. Treatment of glucocorticoid-resistant or
relapsing Takayasu arteritis with methotrexate. Arthritis. Rheum. 1994; 37:578-582.

[23] Valsakumar AK, Valappil UC, Jorapur V, et al. Role of immunosuppressive therapy on
clinical, immunological, and angiographic outcome in active Takayasu’s arteritis. J.
Rheumatol 2003; 30:1793-1798.

[24] Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumour necrosis factor therapy in
patients with difficult to treat Takayasu arteritis. Arthritis. Rheum. 2004; 50:2296-2304.

[25] Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu
arteritis. Curr. Opin. Rheumatol. 2005; 17:16-24.

[26] Angiletta D, Marinazzo D, Guido G, et al. Eight year follow-up of endovascular repair
of a brachiocephalic trunk aneurysm due to Takayasu’s arteritis. J. Vasc. Surg. 2012;
56:504-507.

[27] Lee BB, Laredo J, Neville R, et al. Endovascular management of Takayasu arteritis: is
it a durable option? Vascular 2009; 17:138-146.

[28] Hu J, Huang H, Zhang X, et al. Stent placement for treatment of long segment (?80
mm) carotid artery stenosis in patients with Takayasu disease. J. Vasc. Interv. Radiol.
2012; 23:1473-1477.

[29] Bonilla-Abadia F, Echeverri AF, Carbonell JP, et al. Multiple endovascular stent-graft
implantations in a patient with aortic thoracic and abdominal aneurysms due Takayasu
arteritis. Rheumatol. Int. 2014; 34:723-725.

[30] Agarwal G, Vats HS, Raval AN, et al. Chronic total occlusion and successful drug
eluting stent placement in Takayasu arteritis induced renal artery stenosis. Clin. Med.
Res. 2013; May 8 [Epub ahead of print].

[31] Liang P, Tan-Ong M, Hoffman GS. Takayasu’s arteritis: vascular interventions and
outcomes. J. Rheumatol. 2004; 31:102-106.

[32] Saadoun D, Lambert M, Mirault T, et al. Retrospective analysis of surgery versus
endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation
2012; 125:813-819.

[33] Salvarani C, Pipitone N, Versari A, et al. Clinical features of polymyalgia rheumatica
and giant cell arteritis. Nat. Rev. Rheumatol. 2012; 8:509-521.

[34] Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology
1990 criteria for the classification of giant cell arteritis. Arthritis. Rheum. 1990;
33:1122-1128.

[35] Kyle V. Laboratory investigations including liver in polymyalgia rheumatic / giant cell
arteritis. Baillieres Clin. Rheumatol. 1991; 5:475-484.

[36] Lee S, Childerhouse A, Moss K. Gastrointestinal symptoms and granulomatous
vasculitis involving the liver in giant cell arteritis: a case report and review of the
literature. Rheumatology 2011; 50:2316-2317.

[37] Scola CJ, Li C, Upchurch KS. Mesenteric involvement in giant cell arteritis. An under
recognized complication? Analysis of a case series with clinicoanatomic correlation.
Medicine 2008; 87:45-51.

[38] Grayson PC, Maksimowicz-McKinnon K, Clark TM, et al. Distribution of arterial
lesions in Takayasu’s arteritis and giant cell arteritis. Ann. Rheum. Dis. 2012; 71:1329-
1334.

Complimentary Contributor Copy